
Kirstine Nielsen of Aarhus University (Denmark) discusses how targeted metabolomics ratios helped build a robust bloodstain time-since-deposition tool.
It is essential to understand the pharmacokinetic profiles and toxicological concerns associated with substances/compounds produced into reference standards trusted for analytical testing and development of high quality pharmaceutical therapies.







